ETEST Delafloxacin (DFX) (0.002-32 µg/mL)
510(k) K192738Ref 540252
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number357302BUDI000812TR 03573026603205 | Date21 May 2026 | StatusActive |
| United States | GUDID listing GUDID | Number03573026603205 | Date6 Apr 2020 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK192738 | Date26 Nov 2019 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade Name
- ETEST® Delafloxacin (DFX)
- Generic Name
- Antibacterial minimum inhibitory concentration (MIC) IVD
- Model / Reference
- 540252 EUDAMEDETEST® Delafloxacin (DFX) GUDID
- Primary DI / UDI-DI
- 03573026603205
- Basic UDI-DI
- 357302BUDI000812TR
- 510(k) Number
- FDA Product Code
- JWY
- EMDN Code
- W0104080501 Mic systems - dilution methods (incl. e-test)
- GMDN Term
- Antibacterial minimum inhibitory concentration (MIC) IVD
- Device Class
- Class B EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 866.1640
- EU market of registration
- France
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Model / Reference | 540252 | — | ETEST® Delafloxacin (DFX) |
| Device Class | Class B | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
The ETEST Delafloxacin (DFX) (0.002–32 µg/mL) is a manual antimicrobial susceptibility test system used for quantitative determination of bacterial susceptibility to delafloxacin. It falls under the category of Manual Antimicrobial Susceptibility Test Systems and is designed for testing non-fastidious Gram-negative and Gram-positive aerobic bacteria, as well as fastidious bacteria.
This device is supplied as a reagent strip-based system and is intended for use in clinical microbiology laboratories. It is classified as a Class II medical device under FDA regulations and has received FDA 510(k) clearance (K192738) and IVDR authorization. The test strips are single-use, and proper storage conditions must be maintained to ensure accuracy and reliability of results.
Other devices from Biomerieux S.A.
Questions
AI-generated answers, 18 Sep 2026
What types of bacteria can the ETEST Delafloxacin be used to test for susceptibility to delafloxacin?
The ETEST Delafloxacin (DFX) is designed for testing non-fastidious Gram-negative and Gram-positive aerobic bacteria, as well as fastidious bacteria. This makes it versatile for a broad range of clinical microbiology applications where bacterial susceptibility to delafloxacin may be relevant.
Is the ETEST Delafloxacin system single-use, and how should the strips be stored?
Yes, the ETEST Delafloxacin test strips are single-use only. To maintain accuracy and reliability, they must be stored under proper conditions as specified by the manufacturer. Incorrect storage could compromise the integrity of the test results.
What regulatory pathways has the ETEST Delafloxacin undergone, and what does that mean for its use?
The ETEST Delafloxacin has received FDA 510(k) clearance (K192738) under the Traditional pathway, demonstrating it is substantially equivalent to a predicate device. It has also obtained IVDR authorization, confirming compliance with European Union regulations for in vitro diagnostic medical devices. This means it can legally be used in clinical microbiology laboratories in the U.S. and EU under the specified regulatory frameworks.
How is the ETEST Delafloxacin system supplied, and what is its primary use?
The ETEST Delafloxacin is supplied as a reagent strip-based system, intended exclusively for manual antimicrobial susceptibility testing in clinical microbiology laboratories. It provides quantitative determination of bacterial susceptibility to delafloxacin, helping guide treatment decisions based on laboratory results.
Properties
Other properties (18)
- Sterile: No
- Implantable: No
- Contains Latex: No
- Human Tissues: No
- Animal Tissues: No
- Microbial Substances: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No
- New Device: No
- Over-the-Counter: No
- Convenience Kit: No
- Combination Product: No
- HCT/P: No
- Premarket Exempt: No
- Serial Number: No
- Manufacturing Date: No